Europe South Asia Asia Pacific Americas Middle East Africa BBC Homepage World Service Education

Front Page



UK Politics







Talking Point
On Air
Low Graphics

Thursday, November 19, 1998 Published at 00:33 GMT


Rationing mental health

New anti-psychotic drugs are much more expensive than the old ones

Almost half of all health authorities are withholding new, more effective drugs for schizophrenics which create fewer side effects, according to a survey.

The National Schizophrenia Fellowship says 45% of health authorities are rationing the new drugs which are often more effective and can prevent four in five suicides by schizophrenics.

The older anti-psychotic drugs often cause side-effects such as facial tics, shaking and problems controlling the tongue which increase the stigma attached to schizophrenia.

Mental health workers say people tend to associate these symptoms with schizophrenia rather than with the drugs.

However, the older drugs are much cheaper than the new ones.

Mental health charity Sane says a yearly course of the new atypical drugs costs £2,000 per person, compared with £20 a person for a course of the old ones.

It conducted its own straw poll of psychiatrists in four parts of the country earlier this year.

The charity found 77% of psychiatrists said that the new drugs were being rationed in the hospitals where they worked.


"It is definitely based on cost," said a spokeswoman. "There is a very, very big difference in cost, but we believe the benefits to patients outweigh the costs."

A recent report by Dr Jonathan Hellewell, consultant psychiatrist at Trafford General Hospital in Manchester, found that the side-effects associated with older anti-psychotic drugs were a big factor in patients deciding to discontinue their medication.

Mental health workers say this can lead to patients being at an increased risk of breakdown and relapse.

Sane says many may end up in hospital as a result, when they could be treated more cheaply in the community.


According to the Health Education Authority (HEA), around one in 100 people in the UK will experience an episode of schizophrenia in their lifetime.

A quarter will recover fully, but up to 15% will have enduring problems.

It is thought that schizophrenia is triggered by a mixture of social and personal factors, including stress, taking illegal drugs and genetic causes.

The HEA says the cost of treating schizophrenia is around £2.6bn a year, including loss of working hours.

Advanced options | Search tips

Back to top | BBC News Home | BBC Homepage | ©

Health Contents

Background Briefings
Medical notes

Relevant Stories

16 Nov 98†|†Health
Schizophrenics fear violent label

26 Oct 98†|†Health
Mentally ill driven to despair over benefits cut threats

21 Oct 98†|†Health
Mentally ill hail landmark ruling

Internet Links

National Schizophrenia Fellowship


Health Education Authority

The BBC is not responsible for the content of external internet sites.

In this section

Disability in depth

Spotlight: Bristol inquiry

Antibiotics: A fading wonder

Mental health: An overview

Alternative medicine: A growth industry

The meningitis files

Long-term care: A special report

Aids up close

From cradle to grave

NHS reforms: A guide

NHS Performance 1999

From Special Report
NHS in crisis: Special report

British Medical Association conference '99

Royal College of Nursing conference '99